Pharmaceutical company
general healthcare issues related to pharmaceutical and biological products; Federal, Food Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Follow-on Biologics; Comparative Effectiveness: Comparative Effectiveness Reserach Act (S.3408); Enhanced Health Care Value for All Act (HR2184); Promoting Innovation and Access to Life-saving Medicine Act (HR1427/S.726); Biologics Price Competition and Innovation Act of 2007 (S.1695); Pathway for Biosimilars Act (HR1548); Health Reform; Affordable Health Choices Act general Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL HILL CONSULTING GROUP
926 Pennsylvania Ave, SE, Washington, DC, 20003, US
BILL K BREWSTER STEVEN E IRIZARRY BILL K BREWSTER STEVEN E IRIZARRY